Home › Funds › Ishara Investments LP › LXRX

Ishara Investments LP position in LXRX

LEXICON PHARMACEUTICALS INC · Health Care

Ishara Investments LP reported holding 320,000 shares of LXRX (LEXICON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$600K, representing 0.51% of its reported portfolio and ranking #37 among its reported holdings. Ishara Investments LP has disclosed LXRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)320.00K sh
Reported value held$600.00K
Portfolio Weight0.51%
First reportedQ4 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Ishara Investments LP's LXRX position evolved

Ishara Investments LP first disclosed a stake in LXRX in Q4 2025 at 880,000 shares (US$1.0M). The position peaked in Q2 2026 at 1,271,000 shares, worth US$3.1M. Across 4 filings, Ishara Investments LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 320,000 shares valued at US$600K — a reduction of -951,000 shares quarter over quarter.. Notable position changes include a 41% increase in Q2 2026 (shares fell 22% over the following quarter), a 75% trim in Q3 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 880.00K $1.01M New
Q1 2026 902.00K $1.41M Add
Q2 2026 1.27M $3.05M Add
Q3 2026 320.00K $600.00K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LXRX and 13F data

LXRX (LEXICON PHARMACEUTICALS INC) is a Health Care company. 26 other funds we track also report a position in LXRX — the largest reported positions include Artal Group S.A. (US$329.3M), Siren, L.L.C. (US$83.3M), Sessa Capital IM, L.P. (US$45.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LXRX

All LXRX fund holders →

FAQ

How long has Ishara Investments LP held LXRX?

Ishara Investments LP has disclosed LXRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Ishara Investments LP's current position in LXRX?

As of Q3 2026, Ishara Investments LP holds 320.00K shares of LXRX (LEXICON PHARMACEUTICALS INC), valued at $600.00K, representing 0.51% of its reported portfolio and ranking #37.

Has Ishara Investments LP been buying or selling LXRX?

In the latest 13F filing (Q3 2026), Ishara Investments LP reduced its position in LXRX. The position peaked in Q2 2026 at 1.27M shares.

Which other funds hold LXRX?

Other major institutional holders of LXRX include Artal Group S.A., Siren, L.L.C., Sessa Capital IM, L.P., among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.